- ROUNDTABLE: Pharmacy’s future in sync with technology
- Actavis' Lo Loestrin Fe patent upheld
- House introduces bill to place age restriction on DXM purchase
- EXPERT BLOG: Provider status for pharmacists — one way or another
- New Rite Aid group VP pharmacy initiatives and clinical services to oversee Wellness Ambassador program
BALTIMORE — The Food and Drug Administration has approved a generic contraceptive made by Lupin Pharmaceuticals, the drug maker said Tuesday.
Lupin announced the approval of levonorgestrel and ethinyl estradiol tablets in the 0.1 mg/0.02 mg strength, a generic version of Watson Labs' Lutera.
Lutera had sales of about $103.6 million during the 12-month period that ended in September 2012, according to IMS Health.